Of note, our observations point to a possible role of one pathway involving T-cells that has so far received relatively little attention in the setting of hypertensive target organ damage: co-stimulation; the expression of both CTLA-4 and its binding partner CD80 was increased in malignant hypertension. The gene discussed is CTLA4; the disease is malignant hypertension.